VenX, LLC, a Nashville-based medical device company focused on advancing the treatment of varicose veins, announced today the start of its first human clinical trials using its latest device for the treatment of varicose veins.

“Having initiated the first-in-man study is a significant milestone for the company and the initial clinical insights have been very encouraging,” said David Landman, VenX’s vice president of business development.

Click here for VenX's company release delineating the device's history.